We are incredibly proud to announce that Dr. Katleen Verleysen, CEO of miDiagnostics, has been named π©πππ π―πππππ πΊππππππππ πΊππππππππ πͺπ¬πΆ 2025!
Under Katleenβs visionary leadership, miDiagnostics has further developed as a leader in revolutionizing diagnostics and quality control testing.
A key focus of our innovation has been the expansion into πππππππππ πππππππ πππ ππππ πππ
ππππ πππππππππ, an area where πππππππππ, πππππ
, πππ
πππππππππππ are paramount.
With our proprietary silicon-based PCR technology, miDiagnostics is transforming the way sterility testing is conducted, ensuring that life-saving therapies, such as CAR-T treatments, can be delivered faster and more reliably.
Reflecting on the evolution of our work, Katleen Verleysen shared:
“π°πππππππππ ππππ πππππππ ππ ππ πππππππ ππππππππ, ππ ππ ππππππππ πππππ, πππ
ππ ππ ππππππππππ πππππ.”
As we continue to develop cutting-edge solutions for ππππ πππ ππππ πππππππ πππππππππππππ, we remain committed to providingΒ πππππ πππ ππππππππ πππππππππ πππππππ, that helps accelerate access to personalized treatments, ultimately transforming the lives of patients around the world.
Read the full article here πhttps://www.eubusinessnews.com/issues/q3-2025/